These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate. Brown WA; Silver MA J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204 [TBL] [Abstract][Full Text] [Related]
3. Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: two-year outcome. Heresco-Levy U; Greenberg D; Lerer B; Dasberg H; Brown WA J Clin Psychiatry; 1993 Feb; 54(2):59-62. PubMed ID: 8095259 [TBL] [Abstract][Full Text] [Related]
4. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
5. Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse. Heresco-Levy U; Greenberg D; Lerer B; Dasberg H; Brown WA Isr J Psychiatry Relat Sci; 1995; 32(4):268-75. PubMed ID: 8641856 [TBL] [Abstract][Full Text] [Related]
6. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels. Jayaram G; Coyle J; Tune L J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342 [TBL] [Abstract][Full Text] [Related]
7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Roose K Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of neuroleptic in patients receiving depot fluphenazine. Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997 [TBL] [Abstract][Full Text] [Related]
9. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients. Faraone SV; Brown WA; Laughren TP J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923 [TBL] [Abstract][Full Text] [Related]
10. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977 [TBL] [Abstract][Full Text] [Related]
11. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650 [TBL] [Abstract][Full Text] [Related]
12. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881 [TBL] [Abstract][Full Text] [Related]
14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients. Wistedt B Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878 [TBL] [Abstract][Full Text] [Related]
15. Stabilization and depot neuroleptic dosages. Weiden P; Schooler NR; Severe JB; Lee JH; Schulz SC Psychopharmacol Bull; 1993; 29(2):269-75. PubMed ID: 8290676 [TBL] [Abstract][Full Text] [Related]
16. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. Cookson JC; Kennedy NM; Gribbon D Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879 [TBL] [Abstract][Full Text] [Related]
17. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)]. Balon R; Kabesh Ia; Papezhova G Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437 [TBL] [Abstract][Full Text] [Related]
18. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome. Turbott J; Villiger J; Hunter L Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373 [TBL] [Abstract][Full Text] [Related]